Exclusive Summary

• Patent expiry opens global generic market for Diquafosol Sodium Eye Drops, making Chinese suppliers cost-effective options.
• Large and growing global dry eye disease patient population creates unmet need, with Diquafosol Sodium Eye Drops offering proven clinical efficacy.
• Product benefits from established usage in Asian markets and a solid foundation for international registration and compliance, facilitating replication in similar markets.
• Significant cost advantage over originator product addresses demand for affordable medicines in regions with budget constraints.